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Abstract
Introduction: Despite the attempt to make decisions based on evidence, doctors still 
have to consider patients’ choices which often involve other factors. In particular, 
emotions seem to influence the way that options and the surrounding information are 
interpreted and used.
Objective: The objective of the present review is to provide a brief overview of research 
on decision making and cancer with a specific focus on the role of emotions.
Method: Thirty-nine studies were identified and analysed. Most of the studies inves-
tigated anxiety and fear. Worry was the other psychological factor that, together with 
anxiety, played a crucial role in cancer-related decision-making.
Results: The roles of fear, anxiety and worry were described for detection behaviour, 
diagnosis, choice about prevention and curative treatments and help-seeking behaviour. 
Results were inconsistent among the studies. Results stressed that cognitive appraisal and 
emotional arousal (emotion’s intensity level) interact in shaping the decision. Moderate 
levels of anxiety and worry improved decision-making, while low and high levels tended 
to have no effect or a hindering effect on decision making. Moderating factors played an 
under-investigated role.
Conclusions: Decision making is a complex non-linear process that is affected by several 
factors, such as, for example, personal knowledge, past experiences, individual differ-
ences and certainly emotions. Research studies should investigate further potential mod-
erators of the effect of emotions on cancer-related choice. Big data and machine learning 
could be a good opportunity to test the interaction between a large amount of factors 
that is not feasible in traditional research. New technologies such as eHealth and virtual 
reality can offer support for the regulation of emotions and decision making.
Keywords: emotion, anxiety, fear, worry, cancer, health behaviour, patient’s decision making
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Introduction
Cancer remains a worldwide leading cause of death and constitutes a significant burden to patients and their families, despite the fact that 
cancer mortality rates are estimated to decline as a result of increased emphasis on early detection, improved treatment methods and the 
adoption of healthy lifestyles [1, 2]. A cancer diagnosis remains a life time-point where the person has to make choices regarding available 
treatments and actions to be taken to face the care pathway, other than life changes.
Despite the attempt to make decisions based on evidence, studies in psychology, economics and also in the medical field show that often 
emotions prevail, affecting the thinking process and therefore the choice [3–6].
Decision-making has acquired a crucial importance in cancer care in the last 20 years, since the introduction of the patient-centred approach 
which emphasises the new relationship between patients and doctors and the increasingly common model of shared decision-making. Patients 
are not passive recipients anymore but active participants of the care process. In this vein, patients are required to take several decisions during all 
phases of the disease. Despite the doctor’s efforts to provide the patient with all necessary objective information for reaching a good shared deci-
sion, often the patient’s choice is affected by other factors than objective information, emotion being among the most relevant. Fear of surgery or 
of possible side effects might delay or stop the decision to undergo specific clinical procedures or treatments [7]. Particularly, in life-threatening 
health conditions such as cancer, evidence shows that emotions such as fear and anxiety affect the choice [8]. For example, fear of adverse events 
leads most patients to refuse participation in clinical trials [9]. Negative emotions elicited by the new (negative) situation often means that atten-
tion is focused on the negative aspects [10], producing a distortion in risk perception and, consequently, suboptimal health decisions [3]. For 
example, information presented during the first consultation is often forgotten or very difficult to memorise because of patients’ emotional state 
[11, 12]. Also, smokers tend to postpone the decision to quit smoking because of the positive visceral emotions they feel (e.g. hedonistic pleasure 
related to smoking) or because of the attribution of the disease to uncontrollable factors (e.g., genetic predisposition, environmental pollution and 
so on) in order to cope with fear [13]. Emotions, as well as cognition, are a fundamental component of the decision-making process.
Emotions
A definition of the term ‘emotion’ is not so easy, as Izard showed in his interview with scientists working on emotions [14]. ‘Emotion consists 
of neural circuits (that are at least partially dedicated), response systems and a feeling state/process that motivates and organises cognition 
and action. Emotion also provides information to the person experiencing it and may include antecedent cognitive appraisals and ongoing 
cognition, including an interpretation of its feeling state, expressions or social-communicative signals and may motivate approach or avoid-
ant behaviour, exercise control/regulation of responses and be social or relational in nature’ [14, p 367]. The complexity of emotion can be 
explained by its multi-aspect nature.
The main approaches in the study of the structure of emotion are two: the categorical and the dimensional. While the categorical approach 
affirms the existence of several distinct emotions, such as fear, anger, disgust, happiness and sadness [15], the dimensional approach 
describes the structure of two dimensions of positive and negative affect [16] or two dimensions of valence (a continuum that varies from 
unpleasant to pleasant) and arousal (from calm to excited) [17].
Valence and arousal were identified as the most basic dimensions [18] that inform the evaluative appraisal (the cognitive meaning attributed 
to the emotion). The importance of appraisal in the experience of emotion can find its root in the theories of Cannon [19, 20] and Bard [21]: 
in order to be experienced as emotion, the emotion needs a cognitive evaluation to be associated with physiological changes (arousal). This 
theoretical position was developed further by the appraisal theories that foster the importance of the cognitive evaluation of the event. 
Appraisal consists of the rapid and often unconscious evaluation of a stimulus or an event, and that eventually determines and differentiates 
the emotions felt subjectively [22], by using information from the event in its context and from the individual’s mental map (e.g. personal 
knowledge, beliefs, history) [23]. The criteria for the event evaluation on which most theoreticians agree are those of novelty, intrinsic pleas-
antness, predictability, goal-relevance, the coping potential and the compatibility with personal and social norms [24]. The high subjectivity 
in evaluating the event provides the reason for the large degree of variability in the characterisation of emotions [25].
The connotative meaning of an event depends on the interaction between valence and arousal. More specifically, arousal impacts on the 
evaluative appraisal of negative stimuli more than of positive stimuli in line with the hypothesis of negativity bias that claims a priority of 
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high-arousing negative stimuli in the processing of affective stimuli. Studies using neuroimaging confirmed the involvement of cognitive 
processes in the experience of emotion [26], showing the activation of brain areas associated with attentional processes, language and 
long-term memory when dealing with several different emotions. The involvement of cognitive processes such as attention and perception 
can be bottom-up that is driven by the stimulus, or top-down when the appraisal of the situation depends on stored knowledge of similar 
situations [27]. Lazarus and Folkman’s [28] transactional model supports the top-down process, postulating that the cognitive assessment 
of an event can trigger emotions such as anxiety, sadness and anger. An example of cognitive assessment influencing emotions is the cata-
strophising phenomenon [29–31]. Catastrophising can be defined as ‘a tendency to magnify or exaggerate the threat value’ of an event 
[32, p 111] and is characterised, other than by magnification, by rumination and defencelessness [28]. According to the transactional model, 
catastrophising is described as a result of underlying beliefs, evaluative appraisal and the evaluation of the ability to cope with the situation. 
Coherently, if a person evaluates a stimulus as threatening and estimates that he or she is unable to handle the situation, this might result 
in catastrophising. Catastrophic interpretations are considered the cognitive precursor of emotional reactions [33, 34] and salient feature 
associated with hypervigilance and fear of an immediate actual threat [35, 36] or anxiety for a more vague, uncertain and future-oriented 
threat [37, 38]. Common aspects in the frameworks describing catastrophising are the relation with emotional responding and coping: an 
increased emotional state and the avoidance of prospects associated with the threat.
Besides an evaluation of valence, arousal and appraisal, emotion can also be defined considering the type of relationship between emotion 
itself and the object or event to be evaluated. From this perspective, emotion can be considered incidental or integral and immediate or 
anticipated.
Incidental emotions are emotions elicited by one situation (for example, a fight with the neighbour or sunny weather) and extended to another 
non-related context (for example, buying a new car or deciding on a new job). They are elicited by a person, a situation or by stimuli not 
normatively relevant to the decision. Chou et al [39] reported evidence on the association between mood (positive, negative or neutral) and 
risk-taking behaviour. They found more risk-taking behaviours in people in a happy mood than in a sad mood. Similarly, people reading a 
newspaper story designed to induce a negative mood tended to overestimate the probability for various potential causes of death than those 
who read a newspaper story designed to induce a positive mood [40].
Despite the fact that incidental emotions should not affect judgement and decisions on unrelated tasks (the type of new car to buy after a 
fight with a neighbour or on a sunny day), these emotions actually have been shown to shape risk perception and decisions. For example, 
while a patient may feel fear because of a cancer diagnosis, at the same time he/she continues to feel anger over a previous argument with 
his/her spouse. Despite the fact that such incidental emotion (anger over the spouse) is not normatively relevant for the choice [41], it can 
still be salient and meaningful and affect treatment-related information processing and decisions. This is especially true for people low in 
numeracy for whom numerical expressions of risk have little meaning [42].
In contrast to incidental emotions, integral emotions are experienced at the time of the decision in response to a new or threatening situation 
[43]. For example, the fear someone feels when a bear suddenly appears in front of him/her, the anxiety a person feels about the potential 
outcome of a risky choice [44] or the fear, anger and sadness experienced related to cancer [42]. The adaptive function is particularly evident 
when dealing with integral emotion: it provides information about whether the stimulus or event is relevant for the individual’s present or 
future survival or well-being [22] and modulates basic cognitive processes, such as attention, perception and memory, involved in informa-
tion processing and stimulus evaluation [45].
Integral emotions can, in turn, be categorised into immediate and anticipated emotions.
While immediate emotion is an immediate visceral reaction triggered by the situation, anticipated emotion is defined as the effect that people 
expect they will feel once those outcomes take place [46]. Anticipated emotions are particularly important for decision making where the 
individual has to anticipate the possible consequences (including emotions) of a choice. This sort of simulation consists of pre-experiencing 
the event and pre-feeling the anticipated emotion and is affected by previous experiences and memories of similar events [47]. To make a 
choice, the decision maker anticipates the pleasure of the first vacation assuming good weather and the displeasure of the vacation assum-
ing bad weather. In the oncological field, while making the decision whether to undergo risk-reducing mastectomy (RRM) or to adhere to 
a surveillance programme, a healthy woman with a BRCA mutation increasing the risk of breast cancer will anticipate emotions associated 
with the outcomes of the options to be selected. For example, the relief associated with the risk reduction following the RRM or the regret 
associated with the possible occurrence of cancer in case of the selection of a surveillance programme. These feelings are weighted by the 
perceived likelihood of good or bad outcomes (in our example, no cancer or occurrence of cancer), respectively, and the resulting feelings are 
combined to obtain an average feeling of anticipated pleasure [48].
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Emotion and decision making
As a recent review showed [44] emotions are the dominant driver of most meaningful decisions in life [46, 49–52]. Decisions can be viewed 
as a conduit through which emotions guide everyday attempts to avoid negative feelings (e.g. guilt and regret) and increasing positive feelings 
(e.g. pride and happiness), even when they do so without awareness.
However, for a long period, emotions have been excluded from the decision-making domain. Normative approach, promoted by Von Neuman 
and Morgerstern [53], affirmed that the ‘best choice’ is the choice able to maximise the subjective expected utility. In this model, the 
decision-maker is represented by the ‘Homo Oeconomicus’ completely rational, with a stable preference system able to evaluate all options 
and to choose the one with a higher utility. In this vein, by maximising utilities, decision makers maximise pleasure and minimise pain [48]. 
Accordingly, emotions are roadblocks that hinder the process of achieving an optimal decision. In the 60s, a new approach was proposed by 
Simon [54] and Tversky and Kahneman [55] highlighting the limits of human rationality, describing the so-called ‘Homo Heuristicus’. Simon’s 
‘Bounded Rationality’ illustrates the psychological and contextual factors affecting judgement and decision, positing that human behaviour 
is determined by the ‘inner environment of people’s minds’ [54]. Two decades later, Tversky and Kahneman [55] provided another milestone 
with the introduction of the ‘Prospect Theory’, showing that the construction of preferences and risk perception depend on the individual’s 
status quo that influences the interpretation of the absolute value of an option. Despite the importance of these contributions, emotions 
are not yet explicitly considered, focus still being strongly on cognitive processes [46]. Only since the 80s, an ‘Emotion Revolution’ has been 
directed, stressing the role of affective processes in decision-making [56]. In this revolution, Loomes and Sudgen’s [57], Bell’s [58], Zajonc’s 
[59] and Damasio’s [60] contributions are important milestones.
Zajonc [59] argued that affective reactions to stimuli are often the very first reactions, occurring automatically and subsequently guiding 
information processing and judgement. This idea of emotion as a guide for judgement and decision making is strongly supported by the 
somatic marker hypothesis [60]. According to this hypothesis, emotions are the result of bodily sensations associated to specific events 
through experience, that eventually are translated into mental images stored in the long-term memory. When a person starts thinking about 
the possible consequences of a decision, emotions may be triggered by emotion-laden images stored in memory and associated with those 
consequences. When negative, emotions sound as an alarm. When positive, they are a signal of incentive. According to this hypothesis, 
automatic bodily arousal responses (somatic markers) are triggered by emotion-laden events that are consequently marked with an emo-
tional signal. Of key importance in the use of emotions in decision making is the personal interoceptive ability that is the ability to detect 
subtle bodily changes: individuals who are high in interoception use such body information in decision making more than people with a low 
interoceptive ability [61]. The ability to detect even subtle bodily changes associated with an emotional reaction can help the person better 
evaluate the event.
According to these approaches, emotion helps the decision maker to assess the value of the option in three ways: (i) driving the search for 
information—‘feeling as information mechanism’ [62]; (ii) guiding the identification of salient information [63] and (iii) highlighting the relevant 
aspects of the situation contributing to preferences construction [64].
In particular, emotion seems beneficial when it is not possible or easy to determine which option is better from a cognitive or analytical 
comparison. When choice options present the same normative value or when the decision is too complex, emotions can help limit the range 
of information to take into account the inference actually drawn from potential infinity and the set of options among which to choose [65]. 
In this argument, De Sousa [66, p 276] stated that ‘emotions render salient only a tiny proportion of the available alternatives and of the 
conceivable relevant facts’.
Effects of emotions
Theories of emotion and decision making argued that part of the calculation of the value of decision options should include the nature of the 
emotional response elicited by those options and associated potential outcomes. However, how this occurs varies depending on the decision 
attributes assessed and the specific personal emotional reaction [45].
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Several studies [60, 67–69] showed that individuals with emotional dysfunctions tend to perform poorly compared with those who have 
intact emotional processes. Bechara et al [70, p 1294] argued that the autonomic response is used as ‘nonconscious signalling that reflects 
access to records of previous individual experience—specifically records shaped by reward, punishment and the emotional state that attends 
them’. In the same line of thinking of the positive role of emotion in decision making, regret may lead people to be conservative in their deci-
sion, helping them avoid the alternative with the worst outcome [57]. A healthy woman with BRCA mutation, anticipating the negative emo-
tion that she might feel in case of cancer occurrence after deciding on active surveillance, might lead her to actually choose RRM in order to 
avoid cancer-related death. Similarly, a prostate cancer patient might prefer active surveillance instead of surgery because of the regret he 
anticipates thinking of the subjective unacceptable surgical side effect of sexual impotence.
On the other hand, although emotions can accurately guide behaviour, reliance on them can also be misleading. As Slovic et al [71, p 319] 
argued, ‘if it was always optimal to follow our affective and experiential instincts, there would have been no need for the rational-analytic 
system of thinking to have evolved and become so prominent in human affairs’. Examples of the negative impact of emotion can be find in 
the adoption of lifestyle behaviours. Smokers tend to overweight the visceral emotions connected with smoking (e.g., hedonistic pleasure 
related to the smoking’s action), with an under evaluation of risks related to cigarettes [13].
The negative effect of emotions on decision making can be explained by Mathews and MacLeod’s [10] model on information processing. 
According to this model, high levels of emotion lead the individual to focus on information congruent with the felt emotion, and consequently 
to a biased interpretation of the stimulus or the event. For example, high levels of fear, anxiety or anger induce people to focus on negatively 
connoted information, increasing the negative interpretation of the situation. While emotion can have a beneficial effect in the information 
search, as hypothesised by de Sousa [65, 66], high-intensity levels of emotion may then also impair the information search, interpretation and 
choice. During the first consultation with the oncologist in which a cancer diagnosis is provided, the patient’s emotional state induced by the 
negative emotion-laden information may lead them to forget or not memorise part of the consultation’s content [11].
Aim
The present review was carried out to explore the role of emotion in patient’s decision-making related to cancer. The specific purpose was 
to identify the main factors associated with the emotion-decision-making relationship and to investigate the beneficial or hindering role in 
choice behaviour in order to eventually propose strategies to improve cancer patients’ decision-making [72].
Methods
Data sources and literature search strategy
This work offers a narrative and critical overview of the chief findings from previous qualitative and quantitative studies identified in a 
literature search on the relation between cancer, decision-making and emotion. The methodology approach used to treat the data was 
settled according to Collins et al criteria [72]. In particular, a qualitative approach was used, focusing on the main issues associated with the 
emotion-decision-making relationship. Studies published until 2017 were considered. The search was conducted using the PubMed and Ovid 
databases; and a set of keywords or a combination of them was used: emotion, cancer, decision and choice. Considering the main aim of this 
narrative review, a series of the inclusion and exclusion criteria were fixed. Inclusion criteria: (a) prospective and retrospective, case-control, 
longitudinal, cohort studies, randomised and clinical trials, systematic review, narrative review and meta-analysis; (b) studies concerning 
cancer patients and (c) studies published in the English language. Exclusion criteria: (a) studies that evaluated the role of emotions in non-
oncological fields; (b) articles investigating decision making of special populations (e.g., alcoholics, drug-abusers); (c) studies that assessed the 
role of emotions not related to patients’ decision-making; (d) studies based on animal models and (e) letters, commentaries and editorials.
Notwithstanding the fact that our paper is not a systematic review, we have tracked all identified papers in order to better synthesise 
the collected evidence. According to this, a total of 311 articles were identified (207 from PubMed, 61 from Ovid), some articles were 
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found through other sources (PsychINFO, Researchgate and Google Scholar). Thirty articles were removed because they were duplicates. 
Records screened were 288. After abstracts and titles screening, 224 more papers were excluded because they did not deal with decisions 
made by patients. Sixty-four full-text articles were assessed for eligibility. Twenty-five full-text articles were excluded because they did 
not match the inclusion criteria. Finally, after removal of papers that did not adhere to the inclusion/exclusion criteria, 39 papers were 
selected for the revision.
Results
Among the 39 selected papers, the majority of studies were conducted in the United States of America and were related to choices regarding 
breast cancer screening and treatment, followed by ovarian cancer. The analysis of the selected papers led to the interpretation of emo-
tions as facilitators or barriers of good decision-making in the oncological setting, where good refers to the ability to choose the option that 
increases the probability to obtain the best possible outcome.
Despite the fact that depression includes, among other symptoms, negative emotions such as sadness, depression is a complex psychologi-
cal disorder that needs a more specific in-depth analysis. For this reason, depression will not be considered in this review. The pure effect of 
sadness has not been investigated on cancer patients’ decision-making.
The most studied emotions with respect to patients’ cancer-related decisions were fear and anxiety.
Despite the similarity in arousal that characterises fear and anxiety, we consider such emotional states as different. The main factor that can 
help distinguish the two emotions is the involvement of a conflict and the certainty of a threat. In particular, fear responds to an immediate 
threat, whereas anxiety is a future-oriented emotion [38].
Worry was included in the review, even though it cannot be considered an emotion in all respects, but rather the cognitive side of an emotion, 
and more specifically of anxiety [73, 74].
For each of the considered emotions, a brief definition of the emotion was provided, followed by its effects on decision making, categoris-
ing findings according to a timeline of the common patient’s care pathway, such as detection behaviour, diagnosis, prevention and curative 
treatments.
Fear
Definition
Fear, together with anxiety, is the predominant emotion in cancer patients. Fear can be defined as both a physiological arousal and a subjec-
tive experience resulting from the presence of a threat. In general, it helps patients face a risky situation, where an important loss is possible 
and the individual must ‘decide’ whether to fight or flee the cause of the potential loss. In oncology, the potential cause of the loss is not so 
univocal. The patient might experience fear when dealing with a diagnosis of cancer and its consequences or with the side effects of treat-
ments. See Table 1 for a synthesis of the studies considering the association between fear and decision making.
Choice on detection behaviour
Findings on fear affecting detection behaviour are not consistent. Ghahramanian et al [75] showed no effect of fear on the adoption of 
screening behaviour such as breast self-examination. On the contrary, Talbert [76] showed a positive effect of fear on compliance to breast 
cancer screening, while Ferrat et al [77] showed that fear of screening results was the main barrier to breast detection behaviour. An interest-
ing finding was shown by Smith et al [78] on the interaction between fear and mental imagery. In particular, the authors showed that when 
a cancer-related mental imagery is negatively emotional connoted, and in particular is fear-connoted, the adoption of screening behaviour is 
higher. In particular, women recalling cancer-related memorable messages that evoked fear were more likely to perform detection behaviour, 
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such as breast self-examination or mammogram. The association between mental imagery and fear did not show this effect on prevention 
behaviour, such as for example, the adoption of a healthy lifestyle (physical activity and healthy diet).
Table 1. Role of fear on decision making.
Authors Year Type of study Country Participants Type of  involved choice Effect of emotion
Ghahramanian 
et al [75]
2016 Cross-sectional 
study
Iran 370 women Detection 
behaviour
No effect of fear on breast cancer screening 
choice
Talbert [76] 2008 Observational 
study
USA 120 women Detection 
behaviour 
Positive association between fear and breast 
self-examination
Ferrat  
et al [77]
2013 Qualitative study 
(focus group)
France 34 women Detection 
behaviour 
Hindering effect of fear on breast cancer 
screening behaviour
Smith  
et al [78]
2010 Observational 
study
USA 359 women Detection  
behaviour and 
prevention 
treatment
No association between fear and breast 
cancer prevention behaviour; Positive effect 
of fear on breast cancer detection behaviour
Brown  
et al [6]
2017 Qualitative 
face-to-face 
interviews
UK 36 women with personal or 
family history of cancer or 
personal and familial risk of 
breast cancer
Prevention 
treatment
Preponderance of fear as factor guiding  
decision whether or not to undergo RRM
Hallowell  
et al [85]
2001 Qualitative study UK 49 women with high risk for 
breast or ovarian cancer
Prevention 
treatment
Fear of surgical side effects led  
premenopausal women to postpone  
risk-reducing oophorectomy
Heisey  
et al [83]
2006 Descriptive quali-
tative study
Canada 27 women undergoing,  
candidates or that could  
possibly undergo  
chemotherapy in the future
Prevention 
treatment
Fear of side effect is reported as factor 
negatively affecting the decision to undergo 
chemoprevention
Port  
et al [84]
2001 Observational 
study
USA 43 women with high risk for 
breast cancer
Prevention 
treatment
Fear of side effects is the main reason for 
deciding not to initiate tamoxifen
Soran  
et al [82]
2015 Observational 
study
USA 206 women Prevention 
treatment
Positive association between fear and 
the decision to undergo risk-reducing 
mastectomy
Stafford  
et al [80]
1998 Observational 
study
USA 199 women Prevention 
treatment
Fear of recurrence as main reported factor 
affecting the decision to undergo RRM
Quinn  
et al [79]
2012 Qualitative  
in-depth  
interview study
USA 48 cancer patients Diagnosis and 
Curative 
treatment
Fear mentioned as main reaction to cancer 
diagnosis and main factor affecting thinking 
and decision to participate to clinical trials
Nold  
et al [81]
2000 Survey USA 96 women Curative 
treatment
Fear of cancer or recurrence is the main 
reported factor affecting choice between 
modified radical mastectomy and  
conservative surgery
Dubayova  
et al [86]
2010 Systematic 
review
Slovakia 15 articles Help-seeking 
behaviour
Positive association between high level of 
fear and help-seeking behaviour
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Diagnosis and choice
Quinn et al [79] showed that both the fear resulting from cancer diagnosis and the fear related to the various aspects of clinical trials (e.g. 
side effects) are barriers to adherence to treatment and participation to clinical trials. In particular, in their interviews, fear was mentioned in 
relation to three main concepts: fear associated with cancer diagnosis; fear of clinical trials and fear of the unknown associated with cancer 
diagnosis, cancer treatment and clinical trials. As exemplified by some patients, the first reaction after a diagnosis of cancer is an intense fear 
that seems to freeze patients’ thinking, as exemplified by some participants ‘I was so afraid. I was sure I was going to die when I found out I had 
cancer. It was terrifying. I could not think about anything but what I was going to miss…’ or ‘my family and I were so scared when the doctor said 
‘cancer’; I don’t think I heard anything else that was said’. The role of fear in making patients decide not to participate in a clinical trial can be 
summarised also by the following patients saying ‘It [the clinical trial] brings up fear, it is frightening—animal testing and the unknown and pain’ 
and I was ‘so scared …I really couldn’t think about a clinical trial at that time’.
Choice on curative treatments
After the adoption of breast conservation surgery (quadrantectomy) as a possible surgical option for women with early-stage breast cancer 
(stage I and II), women could choose between surgeries with similar clinical but different aesthetic outcomes. Stafford et al [80] in a study on 
199 breast cancer patients concluded that fear of recurrence (69% of the recruited patients), followed by fear of deformity, mutilation, loss 
of breast or body image (13%) and fear of radiation and concerns over radiation treatments (12%) were the main factors affecting patients’ 
preferences for radical mastectomy instead of quadrantectomy. Nold et al [81] found similar results investigating what affected the choice 
between breast-conserving surgery and modified radical mastectomy in breast cancer patients. Using both quantitative and qualitative data, 
they found that fear of breast cancer or of recurrence was the most influential factors for choosing modified radical mastectomy. Again, in 
an observational study, psychological factors affecting the choice of contralateral prophylactic mastectomy and satisfaction with the surgery 
were examined through a questionnaire >1 year after the surgery in 206 women with unilateral breast cancer [82]. The descriptive analysis 
showed fear of a new breast cancer or of cancer recurrence as the most influential factor for the choice despite objective evidence. Similarly, 
a qualitative study showed the positive association between fear about cancer and risk-reducing mastectomy [6]: patients participating in 
the study did not use objective risk estimates nor consider the risks and benefits of RRM, rather they were guided by the negative emotion 
of a potential future dramatic outcome. For example, a patient participating in the study affirmed she knew her personal objective risk to be 
5%–10% (in italics the patient’s verbatim) but she explained her decision for prophylactic mastectomy as a response to a feeling in my head 
that risk was about 80%. Differences in decision-making in the considered sample were affected by an attempt to balance fears of breast 
cancer and prophylactic mastectomy, with patients without breast cancer experiencing their vulnerability with less emotional intensity than 
those with breast cancer. That fear was the drive for the decision was confirmed by the difficulty in making the choice because the fear of 
cancer was counterweighed by the fear of surgery. As the authors posited, fear reduction and protection from future regret became the 
primary decision-making goal of the patients they interviewed.
Choice on prevention treatments
Different results have been shown for detection and prevention behaviour. In a study analysing the effect of emotion arising from memorable 
messages about breast cancer on women’s prevention and detection behaviour, results showed fear to be the factor promoting detection 
behaviour, while no effect or hindering effect of fear was found on prevention [78]. More specifically, in deciding about chemoprevention, 
fear of side effects seems to move the attention away from the long-term benefits of the treatment [78, 83, 84], leading individuals to refuse 
preventive treatment.
Heisey et al [83] concluded that fear of side effects was one of the barriers for choosing to undergo chemoprevention. However, no explicit 
mention of this emotion was brought up as an example by the authors nor was it specified in the coding process they used in categorising 
participants’ answers which led to this conclusion. Rather concerns about side effects, such as ‘the long-term effects would concern me…’ were 
reported.
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In another study [84], patients were assessed on their attitude towards taking tamoxifen as preventive therapy. Among the 43 patients eli-
gible to take tamoxifen, only 2 (5%) decided to go for it. Fear of side effects was the main reported reason for not accepting the preventive 
therapy, with the most feared side effects being endometrial cancer and thromboembolic events.
Similarly, fear of surgery and fear of the consequences of surgery (e.g. symptoms related to menopause) have been demonstrated to be the 
most important barriers for risk-reducing salpingo-oophorectomy [85]. In describing the factors affecting high-risk premenopausal women’s 
decision about prophylactic oophorectomy, in a retrospective study by Hallowell [85] showed that 17 out of 23 patients who decided on 
prophylactic surgery reported that fear of cancer was highly influential in their decision. They also asserted that after surgery they did not 
feel afraid or worried anymore, rather they felt a sense of relief. Conversely, women in the screening programme showed a more ‘objective’ 
interpretation of the term risk: they reported awareness of the fact that, given the personal risk, cancer can also not occur, while women who 
underwent surgery reported the belief of certainty of cancer occurrence. The hindering role of such emotion in the decision about prophy-
lactic surgery was driven by the fear of surgical procedures. However, this effect was only temporary since they postponed the decision of 
surgery for a few months. It should be noted, however, that in this paper, especially when talking about the fear of surgical procedures, the 
authors used fear and anxiety interchangeably.
Seeking help
A systematic review [86] showed that high levels of fear were associated with earlier help-seeking in cancer patients. More difficult to under-
stand was the effect of the low-intensity level of such emotions. However, in that systematic review, the authors included in the concept of 
fear also ‘being worried’, anxious’, ‘in panic’ or ‘feel death anxiety’, making the conclusion more complex.
Anxiety
Definition
Studies in the literature have often questioned the differentiation between the emotion of fear and anxiety. Recent works investigating the 
biological substrate of fear and anxiety showed important differences in brain activation although some overlap is present [87]. Moreover, 
an opposite correlation has been demonstrated between these two emotions (assessed using self-reported measures) with pain perception, 
where fear is inversely related and anxiety is positively related to pain [38]. Cowen and Keltner [88] recently demonstrated the existence of 
gradients between emotions from anxiety to fear to horror to disgust, where the boundaries between categories of emotion are fuzzy rather 
than discrete. In their experiment, they demonstrated that anxiety and fear were elicited by many of the same videos, as for fear and horror, 
but anxiety and horror were elicited by few of the same stimuli. They argued that the majority of categories of emotion shared blurred bound-
aries with other categories shaping the individual experience. However, categories have more semantic value than the affective dimensions 
in explicating people’s reports of emotional experience. Coherently with this finding, we will use anxiety as an emotion different from fear. In 
particular, we will consider anxiety as an unpleasant emotional response specific for a threatening or dangerous situation that possibly may 
occur in the future [38]. See Table 2 for a synthesis of the studies considering the association between anxiety and decision making.
Choice on detection behaviours
Studies on the role of anxiety in cancer-related decisions showed inconsistent results both in detection and preventive behaviour and in 
treatment choices. While some studies indicated that high levels of anxiety promoted compliance with mammographic screening [89, 90], 
others highlighted a hindering role of this emotion. In a survey to assess the individuals’ motivations for genetic testing to determine skin 
cancer risk, Fogel et al [89] showed that, among the four main factors that accounted for the desire to pursue genetic testing, anxiety played 
the biggest role. In this study, anxiety was considered in relation to genetic testing for skin cancer, its results and unintended consequences. 
The results of the research showed that higher scores in anxiety predicted low desire for genetic testing.
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Table 2. Role of anxiety on decision making.
Authors Year Type of study Country Participants Type of  involved choice Effect of emotion
Bober  
et al [97]
2004 Clinical trial study USA 129 women Prevention 
treatment
Positive association between anxiety and the  
decision to assume tamoxifen
Brain  
et al [91]
1999 Study reports 
cross-sectional
UK 833 women Detection 
behaviour
Non-significant U-shape trend between general 
anxiety and breast self-examination frequency
Cameron  
et al [90]
1998 Randomised clini-
cal trial 
New Zealand 140 women Detection 
behaviour
Increase of breast self-examination in high-anxiety 
women using tamoxifen
Dillard  
et al [98]
2013 Quantitative 
study
USA 632 women Prevention 
treatment
Positive association between anxiety and the  
decision to assume tamoxifen
Fogel  
et al [89]
2017 Observational 
study
USA 3,783 individuals Detection 
behaviour
High-intensity levels of anxiety predict low desire 
to pursue genetic testing for skin cancer
Hallowell  
et al [85]
2001 Qualitative study UK 49 women with 
high risk for breast 
or ovarian cancer
Prevention 
treatment
High level of anxiety experienced before  
risk-reducing oophorectomy
Hurley  
et al [99]
2001 Qualitative 
observational 
study
USA 94 women Prevention 
treatment
Positive association between anxiety and the  
decision to undergo prophylactic oophorectomy
Kash  
et al [93]
1992 Cross-sectional 
study
USA 217 women Detection 
behaviour
High level of anxiety predicted poor adherence to 
clinical breast examination and to regular breast 
self-examination
Lerman  
et al [94]
1995 Observational 
study
USA 105 women Detection 
behaviour
Positive association between anxiety and intention 
to perform genetic testing breast-ovarian cancer
Lerman  
et al [92]
1990 Qualitative study USA 910 women Detection 
behaviour
Reported high anxiety about screening was 
associated with low frequency of mammography 
examination
Madalinska  
et al [102]
2007 Longitudinal 
observational 
study
Netherlands 160 women Prevention 
treatment
No association between anxiety and the decision 
to undergo risk-reducing salpingo-oophorectomy
Meiser  
et al [101]
2013 Cohort study Australia 571 women Prevention 
treatment
No association between anxiety and the decision 
to undergo risk-reducing salpingo-oophorectomy
Miller  
et al [96]
2011 Qualitative study USA 84 women Detection 
behaviour
Experiential avoidance moderates the associa-
tion between anxiety and decision to perform 
mammography
Schwartz  
et al [100]
2012 Observational 
study
USA 465 women Detection 
behaviour and 
Prevention 
treatment
Positive association between pre-counselling  
anxiety and intention to use mammography; 
No association between anxiety and the uptake of 
risk-reducing salpingo-oophorectomy
van Driel  
et al [103]
2016 Prospective 
study 
Netherlands 486 women Prevention 
treatment
No association between anxiety and risk-reducing 
mastectomy
In a randomised clinical trial on tamoxifen used as preventive therapy, Cameron et al [90] showed that high-anxiety women using tamoxifen 
are more like to perform breast self-examination. Brain et al [91] examined the effect of anxiety on the frequency of breast self-examination 
in women with a family history of breast cancer and the presence of differences between general anxiety and cancer-related worry in 
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performing the exam. Patients were divided into three groups according to their tendency to perform breast self-examination: infrequent 
self-examination, regular self-examination and excessive self-examination (performed weekly or more). The results reported a non-significant 
U-shape trend, with appropriate self-examiners presenting less anxiety than the other two groups. Significant differences in the three 
considered groups were found in cancer-related worry, with results showing a linear relationship between cancer-related worry and self-
examination frequency. Other studies showed the discouraging role of high anxiety from practicing early detection examination [92, 93]: 
high level of anxiety predicted poor adherence both to mammography and breast self-examination in women at high risk for breast cancer.
Some studies showed that the effect of anxiety on decision making interacts with other psychological factors. For example, knowledge 
about cancer, genetic testing and the perceived benefits of testing impact on the intention to have genetic testing depending on the level 
of anxiety [94]. More specifically, women with high anxiety about breast cancer and an increased knowledge on genetic testing showed an 
increase interest in testing for breast cancer mutation. However, as anxiety increased, women’s comprehension of information provided 
during counselling decreased. In this case, anxiety may act as an obstacle to knowledge. However, comprehension does not impact the 
interest on genetic testing when the anxiety level is very high. Anxiety may indeed motivate health behaviour not necessarily through care-
ful information processing and an increasing knowledge of treatment options: individuals high in anxiety about cancer may be motivated 
to engage in a healthy behaviour to avoid their thoughts or feelings when processing cancer-related information, or in other words, to 
reduce anxiety.
For screening behaviour such as mammography, anxiety acts as a facilitator, especially for women with a high level of experiential avoidance. 
Experiential avoidance is ‘the phenomenon that occurs when a person is unwilling to remain in contact with private experiences (e.g. bodily 
sensations, emotions, thoughts, memories, behavioural predispositions) and takes steps to alter the form and frequency of these events and 
the contexts that occasion them’ [95]. In the oncological context, experiential avoidance acts as moderator in the anxiety-screening behav-
iour relationship. In Miller et al’s study [96], women with low levels of experiential avoidance were more likely to undergo mammography, 
regardless of their level of anxiety. When experiential avoidance increased, women were more likely to undergo mammography if they also 
presented high levels of breast cancer-specific anxiety.
Choice on prevention treatments
Bober et al [97] investigated the decision-making process regarding tamoxifen among high-risk women, taking into account psychological 
variables such as breast cancer anxiety, general anxiety, perceived risk, fear of side effects and family health history. Results showed that 
anxiety related to breast cancer together with an increased cancer risk perception has been associated with the decision to take tamoxifen. 
Similar results were described by Dillard et al [98], according to which women with increased risk for breast cancer and with higher level of 
anxiety were more likely to decide to take tamoxifen.
The facilitator role of anxiety was reported by a study investigating the decision to undergo prophylactic oophorectomy in women over the 
age of 25. Participants were motivated to undergo the surgery by the need for immediate relief from anxiety, independent of family history, 
perceived risk or other variables: the desire to reduce anxiety was the strongest predictor of this procedure [99]. Conversely, three studies 
found no evidence of a relationship between anxiety and uptake of risk-reducing salpingo-oophorectomy [100–102]. A qualitative study [85], 
however, interviewing high risk patients who either underwent risk-reducing salpingo-oophorectomy or adhered to a screening programme, 
found that all women that performed preventive surgery reported a high level of anxiety before the removal of their ovaries and the belief 
that they certainly would have developed cancer in the future despite the personal objective risk.
Inconsistent results on the effect of anxiety were found on the decision to undergo RRM [100, 103]. Schwartz et al [100] showed the predic-
tive role of anxiety on the decision to undergo RRM, following genetic testing. In particular, higher self-reported anxiety was associated with 
the receipt of prophylactic surgery. In contrast, no association was found between anxiety and the decision to receive prophylactic bilateral 
salpingo-oophorectomy. In another study [103] investigating cancer-unaffected women’s intention to choose prophylactic mastectomy after 
performing genetic testing, no association with anxiety was found. The inconsistency in the findings related to anxiety could be explained by 
a non-linear relationship between anxiety and the decision to adopt a specific behaviour. For example, according to Hailey [104], a moder-
ate amount of anxiety facilitates performance, while too much of it has an inhibitory effect, suggesting an inverted U-shaped relationship.
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Seeking help
Opposing results were shown also by a systematic review on the time needed by cancer patients to ask for help in the case of cancer-related 
symptoms [86]. Being clinically anxious before or around the time of symptom discovery does not always increase doctor visits.
Worry
Definition
Worry has been described as ‘a chain of thoughts and images, negatively affect-laden and relatively uncontrollable’ [73, 74]. The content 
of worry typically concerns future events whose outcomes are uncertain, containing the possibility of one or more negative outcomes, and 
involves repetitive thinking about negative self-relevant topics. Its function is to direct attention to a threat, facilitate analytical thinking 
and elicit problem-solving and self-protective behaviour to reduce the threat [105]. Its intimate relation with effect and emotional state 
can be easily understood by Borkovec’s [73, p 561] words, affirming that when worry ‘becomes excessive, uncontrollable and chronically 
present, however, the constant discomfort, disruption and loss of joy in life can become intolerable and may result in a condition known 
diagnostically as generalised anxiety disorder’. See Table 3 for a synthesis of the studies considering the association between worry and 
decision making.
Choice in detection behaviour
Findings on the influence of worry on cancer-related decision-making are inconsistent. A few studies showed that worry increases vigilance 
and that a moderate intensity level of worry increases screening behaviour, such as mammography and early detection practises [106–108], 
as well as having a positive effect on the decision to pursue genetic testing [109]. These results are confirmed by a meta-analysis on 12 per-
spective studies on breast cancer screening behaviour, indicating cancer worry as a motivating factor [110]. Other studies, however, showed 
no dramatic increased or reduced use of mammography with moderate and high levels of worry, respectively [2, 98, 111, 112]. A study on 
university students investigating the intention to perform screening behaviour to prevent or detect skin cancer showed that the effect of 
worry was moderated by students’ ability to imagine the symptoms of skin cancer [113]: the bigger the imagery ability the more intentioned 
students were to adopt prevention and detection behaviours.
Andersen et al [111] results could help understand inconsistent results previously described. They found that worry acts as a facilitator factor 
only at a moderate level: in 6,512 women stratified by a family history associated risk for breast cancer, women reporting moderate levels of 
worry were more likely to use mammography annually, while severe worry may be a barrier to screening and mammography use. This is true 
regardless of the risk status. In another study, Andersen et al [114] assessed worry about ovarian cancer risk in relation to ovarian cancer 
screening, stratifying for family history associated risk. The association between worry and screening behaviour was statistically significant. 
More specifically, women reporting moderate levels of worry about their risk were more likely to screen for ovarian cancer.
Choice on prevention treatments
The increased difficulty in deciding about the most protective actions has been shown by Bober et al’s study [97], in which decision-making 
about tamoxifen among high-risk women was investigated. The results showed the hindering effect of breast cancer-related worry when 
deciding on tamoxifen use. In particular, while breast cancer-related anxiety and heightened risk perception were associated with the deci-
sion to take tamoxifen, worry about side effects was related to the decision to decline treatment.
The role of worry in surgical decision making has been investigated in women who were considering RRM [96, 115]. The results showed that 
what motivated breast cancer patients was fear and worry rather than the objective risk of another breast cancer.
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Table 3. Role of worry on decision making.
Authors Year Type of study Country Participants Type of  involved choice Effect of emotion
Andersen  
et al [111]
2003 Retrospective study USA 6,512 women Detection 
behaviour
Positive association between moderate level of 
worry and decision to perform mammography; 
Negative association between high level of 
worry and mammography use 
Andersen  
et al [114]
2002 Observational study USA 3,257 women Detection 
behaviour
Positive association between moderate level of 
worry and ovarian cancer screening behaviour
Andersen  
et al [111]
2003 Observational study USA 6,512 women Detection 
behaviour
Positive association between moderate level of 
worry and mammography use
Brain  
et al [91]
1999 Study reports 
cross-sectional
UK 833 women Detection 
behaviour
Linear relationship between cancer-related 
worry breast self-examination frequency
Cameron  
et al [109]
2006 A cross-sectional 
design
New Zealand 303 women Detection 
behaviour
Positive association between worry and the 
intention to pursue genetic testing
Cohen [108] 2006 Cohort study Israel 489 women Detection 
behaviour
Positive relation between cancer worry and 
early detection practises for breast cancer
Diefenbach  
et al [107]
1999 Longitudinal  
prospective study
USA 213 women Detection 
behaviour 
Positive association between moderate levels 
of worry and mammography use
Erblich  
et al [106]
2000 Quantitative study USA 135 women Detection 
behaviour
Positive association between worry (intrusive 
thoughts) and breast-self examination
Hay  
et al [110]
2006 meta-analysis of 12 
prospective studies
USA 3,342 women Detection 
behaviour
Positive association between cancer worry 
screening behaviour
Lerman  
et al [112]
1993 Cross-sectional 
study
USA 140 women Detection 
behaviour
Negative association between worry and  
mammography use 
Amuta  
et al [2]
2017 Survey study USA 2,630 participants 
from the Health 
Information National 
Trends Survey
Detection  
behaviour and 
Prevention 
treatment
No effect of worry on detection behaviour and 
prevention treatment
Cameron  
et al [113]
2008 Observational study New Zealand 120 university 
student
Detection and 
prevention 
behaviour
Positive association between worry and skin 
cancer detection and prevention intention, 
moderated by symptoms imagery
Beesley  
et al [115]
2013 Qualitative study UK 60 women Prevention 
treatment
Positive association between worry and the 
decision to undergo contralateral risk-reducing 
mastectomy
Bober  
et al [97]
2004 Clinical trial study USA 129 women Prevention 
treatment
Negative association between worry and the 
decision to use tamoxifen
van Driel  
et al [103]
2016 Prospective study Netherlands 486 women Prevention 
behaviour
Positive association between worry and  
risk-reducing mastectomy
Dubayova  
et al [86]
2010 Systematic review Slovakia 15 articles Help-seeking 
behaviour
No association between worry and help-seeking 
behaviour
Seeking help
On the contrary, a systematic review [86] failed to demonstrate a clear positive effect of worry. In particular, results showed that worry 
doesn’t increase the decision to visit a specialist for the first time, even though it seems to have an impact on the patient’s wish to be treated.
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Discussion
The present narrative review presented the results of 39 articles investigating the role of emotions on cancer-related decision-making. The 
most studied emotions in cancer field were anxiety and fear. Worry was included in the review since its intimate link with affective states 
and often confuses in the research studies with anxiety. The results of the analysed studies confirmed that emotion has an important role 
in health behaviours and can influence the patient’s decision-making. Results on how and when fear, anxiety and worry have an effect are, 
however, inconsistent. As the review showed, emotion can improve ‘normative’ decision-making processes, leading people to choose what 
evidence indicates as the best option; On the other hand, emotion can also be a barrier to it. On the one hand, fear, anxiety and worry seem 
to activate the person to find a solution for a possible threatening outcome. On the other hand, they move the person away from the action 
that promotes better health.
A hindering effect is clearly represented, for example, by a fear of results that prevents people from adopting screening behaviours or the 
fear of side effects that led patients to decide not to undergo long-term beneficial treatments. Consequences that are subjectively dramatic 
and immediate have more impact on the choice. Different personality characteristics and abilities, different past experiences, different 
knowledge and/or education, different life context are all factors that may affect how people emotionally, cognitively and behaviourally react 
to a situation. Only a few studies investigated the presence of moderating factors in the relationship between emotion and cancer-related 
decision-making. Knowing which variables can influence such a relationship can help us understand how to intervene to use patients’ emo-
tions productively.
From the analysed studies, the influence seems to depend on the type of health behaviour involved (e.g. detection versus prevention) on 
the intensity level (or reported arousal) of the emotion elicited by the situation, and on the presence of moderating factors. As for the type 
of health behaviour, results are also not consistent: the lack of control of possible confounding variables or moderators makes a univocal 
interpretation difficult. Studies investigating potential moderating factors could help shed light on differences among the published results.
Cognitive appraisal and emotional arousal interact in shaping the behavioural decision, affecting each other in a circular way where the event 
elicits the emotional reaction that, in turn, affects the cognitive evaluation of the event that, again, may affect a change in emotional reaction.
Considering the importance of arousal in the evaluation of the situation, low arousal of the considered emotion has no effect on patients’ 
decision-making. Instead, moderate levels of arousal have a facilitator effect. On the other hand, high arousal levels have a hindering effect, 
probably by creating a frozen thinking condition as patients reported in Quinn et al study [79]. Several studies, indeed, concluded for a non-
linear function of the effect of emotions: a curvilinear or inverted U-shaped model can explain both anxiety and worry influence, where low 
and extremely high-intensity levels of anxiety and worry lead to a decrease in the facilitator effect on health-related behaviours. A possible 
explanation is that in the first case, there is not enough of an alert or vigilance to push the individual’s information search (screening behav-
iour to detect a tumour); in the second case, the emotional state is so highly activated that it facilitates avoidant behaviour.
The work by Smith et al [78] on memorable image linked to cancer showed that the easier the ability to imagine, recall and anticipate a spe-
cific event, the more likely it was for the individual to perceive an associated emotional reaction. This is in line with Damasio’s [60] somatic 
marker hypothesis and the role of anticipated emotion in decision making [47, 48]: depending on the strength and type of the emotional con-
notation associated with the personal (direct or indirect) past experience with similar event, the emotional reaction the person can feel could 
be more or less salient and more or less vivid. The more salient and vivid the anticipated emotion, the more likely it is to have high-intensity 
emotional reaction affecting the evaluation of the event. Coherently with this position, the theoretical approach of catastrophising explains 
the ‘tendency to magnify or exaggerate the threat value’ of an event [32, p 111] and the association between an increase in intensity of the 
emotional state and an avoidance behaviour. The evaluative appraisal here is crucial: an event evaluated as highly threatening induces an 
emotional reaction that, in turn, may exaggerate the perceived magnitude of the threat.
This could also explain the finding on experiential avoidance as a moderating factor of anxiety [96] and the individuals’ need to avoid nega-
tive feelings about a specific situation (the diagnosis of cancer). Since fear has also been shown to induce avoidance behaviour, it might be 
interesting to test whether experiential avoidance is a moderator also for fear in cancer-related choices. Accordingly, patients with a high 
level of experiential avoidance will try to avoid any experience that can cause negative feelings, such as detection behaviours.
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Coherently with this, some studies highlighted the importance of anxiety and fear in information processing and, consequently, on health deci-
sions [10]. On this argument, Peters et al [4] argued that in health-related decisions affect acts as a spotlight, resulting in more focused attention 
on some information and less focused attention on other information. According to their model, while making a decision as to whether or not 
to have radiation therapy for cancer, the emotional reaction about radiation could lead the individual to process information about the benefits 
of the treatment less carefully while the information about the risks of the treatment is processed more carefully [102]. In this perspective, the 
negative emotional reaction could affect a decision by influencing which information will be processed and therefore the evaluation of all choice 
options: anxiety and fear and worry, thus, could be a barrier and can be an inhibition of careful information processing if not managed.
Cancer-related decisions are taken in a highly uncertain environment. Inside this uncertain environment, emotions might be used by patients 
and clinicians to achieve a better relationship. As observed, emotions have a multiple-impact on cancer-related decision.
Firstly, emotions can both support decision-making process and at the same time roadblock for the choice. High level of anxiety and fear are 
roadblocks in screening decision, but when present at normal levels, emotions may support help-seeking behaviours and reduce patient’s 
delay in early detection of cancer. Coherently, a correct assessment of emotion, for example distinguishing between incidental and integral 
emotions or between immediate and integral ones, can help professionals support patients in the correct attribution of intrinsic value of the 
options. Training patients in their personal interoceptive ability will help them better evaluate the event. The assessment of the intensity, 
moreover, can drive professionals in the individuation of intervention to moderate it. In this way, emotion would really allow the identification 
of value and need associated with the decision which are relevant to the patient, thus facilitating their involvement in shared decision-making.
Considering which factors can moderate the role of emotion is crucial for improving the patient’s decision-making process. Decision making 
is a complex and non-linear process, where the status quo of the decision maker determines how he/she will evaluate the option and perceive 
the associated risk. The status quo includes the person’s knowledge, past experiences, beliefs, emotion regulation ability, coping strategies 
and other personal characteristics. It is not easy for either researchers or clinicians to bring all these factors under control.
Regarding research, the increasing interest in big data and machine learning can help find patterns and trajectories where all factors, previ-
ously investigated in separate research, can be integrated. This type of research can definitely inform clinical practise, with the provision of 
predictive algorithms that, using patients’ bio-psycho-social information can provide physicians with a clear profile of the patient at present 
and his/her probable trajectory in the long-term. Beside big data, eHealth is an optimal opportunity to create the right environment able 
to support patients in their emotional regulation and their decision making. Classical decision aids created within specific smart platforms 
reachable by everybody from everywhere are an example of a tool useful to activate rational thinking, especially in patients who present high 
levels of negative emotions. Moreover, augmented or virtual reality, commonly used for relaxation in cancer patients, can be implemented to 
support the emotion regulation and the process of decision taking in consideration of specific personal characteristics [116].
Conclusion
This narrative review aimed to shed light on the main emotions affecting decision making related to cancer. The results may have important 
implications on health care by means of strategies to be implemented to improve communication provision, emotional reaction management 
and decision making.
Shared decision making between physician and patient and screening campaigns must take advantage of knowledge on how and when 
emotional processing guides patients, facilitating or hindering their active participation in clinical decisions. Involving the patient in health 
decisions requires necessarily an understanding on whether, and eventually how, the patient is under the control of emotions. Decision aids 
that contemplate the interaction between a moderate level of emotion and analytical thinking should be considered for patients, while health 
professionals should integrate into clinical practise easy tools for better understanding the emotional state of the patient, hence individuating 
intervention that ensures a patient’s accurate decision-making process.
Finally, support for patients in the regulation of high-intensity emotional states should also be guaranteed, either through a psychological 
service or by means of new technologies and eHealth. Nowadays, the presence of apps downloadable on the personal smartphone and the 
existence of e-health platforms developed to help patients manage their own clinical condition, both in the medical and psychological areas, 
could make it easier to monitor the patient’s psycho-emotional state and to control the way information is provided.
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Limitations
Some limitations of this study should be considered. Most of the analysed studies used a qualitative method, although often reporting results 
in a quantitative format, to investigate the role of emotions in decision-making. The presented results allow a description of the phenomenon 
but do not allow to clearly distinguish the impact of emotion. All considered studies investigated self-reported emotions and no direct mea-
sure of emotions has been used. If this gives a reason for the importance of subjective and personal evaluation of the emotional reaction, 
there is a risk of confusion of the type of emotions the study is really working on, where anxiety might be called worry or fear and worry 
anxiety. The implication of this possible confusion in clinical practise is still contained, as long as we consider the measurement instrument 
as potential fallacious and therefore only a support for the comprehension of the patient condition.
More controlled studies that consider the interaction with personal characteristics and tasks characteristic (the type of decision to be taken) 
could help us to understand more in detail the specific role of each emotion.
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